BACKGROUND : Markers of fibrinolysis , thrombin-activatable fibrinolysis inhibitor ( TAFI ) , tissue-type plasminogen activator ( tPA ) , and plasminogen activator inhibitor-1 ( PAI-1 ) levels were studied for the evaluation of short-term effects of raloxifene administration in postmenopausal women .
O O O O O O B-GeneOrGeneProduct I-GeneOrGeneProduct I-GeneOrGeneProduct O B-GeneOrGeneProduct O O B-GeneOrGeneProduct I-GeneOrGeneProduct I-GeneOrGeneProduct O B-GeneOrGeneProduct O O O B-GeneOrGeneProduct I-GeneOrGeneProduct I-GeneOrGeneProduct O B-GeneOrGeneProduct O O O O O O O O O O O B-ChemicalEntity O O O B-OrganismTaxon O